The brief

Analyst view

• 30,000+ patients treated at 214 centers globally for tremor disorders via single outpatient procedures.
• Exablate Prime approved by FDA and Health Canada (Feb 2026) with improved operator workflows and MR compatibility.
• The company is private with ~400 employees and offices in Haifa, Miami, Dallas, Shanghai, and Tokyo.

Technical approach

As reported

Targeting

MR-guided beams

Ultrasound waves are aimed using real-time MRI to target brain structures without opening the skull.

Energy

Focused heat

Converging ultrasound waves create precise heat at a focal point to ablate tremor-causing tissue.

Procedure

Outpatient incisionless

Single procedure with same-day discharge, no incisions, no general anesthesia required.

Exablate Prime

Next-gen system

Improved workflows, remote planning, Philips MR compatibility, enhanced cybersecurity (2026).

Show all 4